Over the past two decades, great strides have been made in the field of tissue engineering. Many of the initial attempts to develop an engineered tissue construct were based on the concept of seeding cells onto an avascular scaffold. Using advanced manufacturing technologies, the creation of a preformed vascular scaffold has become a reality. This article discusses some of the issues surrounding the development of such a vascular scaffold. We then examine of the challenges associated with applying this scaffold technology to two vital organ constructs: liver and lung. I n 1985, we hypothesized that a living vital organ could be rationally designed and built for human therapy from cells and degradable polymer scaffolding. This was based on only two pieces of previous work: 1) an acellular artificial dermis by Yannas and Burke (1); and 2) a vascular conduit of contracted collagen and vascular cells (2).Our first reports described the formation of hepatic, intestinal, and pancreatic tissue (3,4). In the ensuing 22 y, the fields of Tissue Engineering and Regenerative Medicine have become established and several tissues are available for human trials or use. In 1998, to overcome the problem of sufficient functional mass for human therapy, we hypothesized that we could build a vasculature as part of the tissue-engineered organ which would provide immediate exchange of oxygenand nutrient-rich blood to the full volume of engineered tissue, much as a transplanted organ functions today. Summarized below are the most recent developments toward an engineered vascularized tissue with emphasis on liver and lung.
VASCULARIZED SCAFFOLD FOR SOLID ORGAN TISSUE ENGINEERINGThe fundamental challenge of developing a tissue for therapeutic use is scaling up the growth of cells from a culture dish to a three-dimensional scaffold. Multilayer cellular constructs are achievable on flat sheets or thin porous scaffolds. However, the creation of tissues for solid organ transplantation must overcome the limited distance of oxygen diffusion.One approach is centered on angiogenesis, or the selfassembly of a vascular network within a scaffold by endothelial and smooth muscle cells. Although on a small scale this is achievable, this approach develops too slowly to support the mass of tissue that is required for an organ transplant, such as a liver. The Tissue Engineering and Organ Fabrication Laboratory at Massachusetts General Hospital proposed the creation of a scaffold with an integrated vascular network (5,6). A capillary-like vascular network within a three-dimensional scaffold can deliver oxygenated blood to within several hundred micrometers of all cells in the scaffold. These vascular networks are designed to replicate features of a capillary network within the bounds of what can be manufactured. Initial work centered on the utilization of photolithography techniques to create molds of capillary-like networks (7-12). The vascular networks of these original molds were designed to have arterial pressure drop across the network wit...